PhD Candidate in Health Sciences: The Norwegian University of Science and Technology (NTNU) is seeking a highly motivated PhD candidate to join the Department of Clinical and Molecular Medicine (IKOM) at the Faculty of Medicine and Health Sciences in Trondheim. This position will involve a three-year research project focused on analyzing immune cells in multiple myeloma patients treated with anti-CD38 monoclonal antibodies.
PhD Candidate in Medicine and Health Sciences
Designation:
PhD Candidate
| Details | Description |
|---|---|
| Research Area | Clinical and Molecular Medicine |
| Location | Trondheim, Norway |
| Eligibility/Qualification | – Relevant Master’s degree or equivalent – Strong academic background in biochemistry, cell biology, immunology, or computational biology – Grade point average of “good” or equivalent – Proficient in English (spoken and written) |
| Job Description | – Analyze immune cells from myeloma patients – Conduct bioinformatics analysis or laboratory work, including cell culture assays and flow cytometry – Contribute to ongoing research projects within the group |
| How to Apply | Interested candidates should submit their application, including a CV and relevant documents, through the NTNU application portal. |
| Last Date to Apply | February 8, 2026 (23:59, Europe/Oslo) |
This is a unique opportunity to contribute to impactful research in the field of healthcare and support the fight against multiple myeloma. We encourage qualified candidates to apply and be part of a dynamic research environment.
